Beauty food Wrinkle
Beauty food Wrinkle reduction A second study investigated the effectiveness of VERISOL ® on wrinkle reduction and the synthesis of important dermal matrix components including type I collagen, elastin and fibrillin, which are key components of connective tissue. In the double-blind, placebo-controlled trial, 114 women aged 45–65 were randomized to receive 2.5 g of VERISOL ® or a placebo, once daily, for 8 weeks. After 4 weeks of treatment, the VERISOL ® group showed significantly reduced eye wrinkle volume of more than 7 %. This positive effect was more pronounced after 8 weeks of supplementation, with some subjects achieving a maximum reduction in eye wrinkle volume of 50 %. Four weeks after the last dose, the VERISOL ® treatment group still showed a statistically significant decrease in eye wrinkle volume of 11.5 %. Healthier, thicker hair As well as having beneficial effects for the skin, VERISOL ® also supports healthy hair. Proof of this comes from a randomized, placebocontrolled study that showed supplementation with VERISOL ® leads to improved hair structure because it significantly increases hair thickness and proliferation of human hair follicle cells. In this study, 44 healthy women aged between 39 and 75 each received a daily dose of 2.5 g VERISOL ® or placebo for 16 weeks. At the end of the supplementation period, use of VERISOL ® resulted in a significant increase in hair thickness, while in the placebo group, there was a slight decrease. Diminishing cellulite A third study investigated the ability of VERISOL ® to reduce cellulite. In this double-blind, placebo-controlled study, 105 women aged between 24 and 50 years received a daily dose of 2.5 g VERISOL ® collagen peptides or a placebo (maltodextrin) and were classified as being of normal weight or overweight, depending on their BMI. After the treatment period, the skin tissue of those in the VERISOL ® group was measurably more compact, indicating a strengthening of the connective tissue. Each group was assessed for cellulite, both visually and using the “pinch” test. After only 3 months and compared with the baseline readings, a statistically significant cellulite reduction score was observed in the treatment group. Stronger nails too Although measuring the impact of VERISOL ® on nail health was not the objective of these studies, an improvement in nail quality among the participants was noticed as a positive side-effect. Anecdotally, there is a long-held belief among consumers that collagen is good for 46 No. 3 November/December 2021
Beauty food the nails. However, there has not been proper scientific evidence of this – until now. For the first time, a clinical trial has investigated the efficacy of a specific dosage (2.5 g/day) of VERISOL ® on nail growth and brittle nail syndrome. In this open, single-centre clinical trial, a total of 25 healthy women received a daily dose of 2.5 g VERISOL ® for 6 months, followed by a 4-week observation period. In terms of nail growth, taking VERISOL ® led to clear improvements after 12 weeks of treatment: Daily supplementation promoted a 10 % increase in nail growth. This rose to 12 % after 24 weeks, and 15 % four weeks after the last dose. Frequency of cracked or chipped nails also decreased significantly. And even after the washout phase, 21 participants (88 %) showed excellent/ good/fair improvement in brittle nail syndrome symptoms such as peeling, edge irregularities and roughness. At the end of the study, most participants (80 %) agreed that VERISOL ® had improved the appearance of their nails, and were totally satisfied or satisfied with its performance. placebo. Both were instructed to take a daily dose of 5 g for 8 weeks. The study period was subsequently extended by 4 weeks without further product administration to investigate the ongoing effect of the treatment. Overall, the study results proved that – compared to placebo – a continuous intake of fish-derived VERISOL ® F leads to a statistically significant improvement in skin elasticity. Additionally, the eye wrinkle volume of the VERISOL ® F group decreased signifi cantly. In conclusion, Proksch et al were able to prove that a daily intake of 5 g of fishderived VERISOL ® has a positive impact on skin elasticity and eye wrinkle volume reduction. Multiple opportunities for brands GELITA continues its scientific research, developing and enhancing the potential for its BCP ® portfolio to be used in successful nutricosmetic applications. With an ability to deliver proven benefits into markets that so many consumers are invested in, these ingredients offer manufacturers an easy way to add credence to beauty from within products – not only in the realms of skin health, but also for hair and nails. The company is always on the lookout for innovative ways to enhance its already wide-ranging product portfolio. And with its marine BCP ® VERISOL ® F, GELITA offers brands a way of reaching consumer groups who would shy away from traditional collagen as an ingredient. References 1 https://www.loreal-finance.com/en/annual-report-2020/cosmetics-market-2-1-0/ [last accessed August 2, 2021] 2 https://www.reportlinker.com/p06089053/?utm_source=GNW [last accessed August 2, 2021] 3 Nutrafoods (2020) 1:127-133. DOI 10.17470/NF-020-0018 A marine collagen alternative Collagen peptides are usually derived from natural raw materials obtained from animals like cattle. But with more and more consumers turning away from meat, whether for dietary, ethical or religious reasons, GELITA has developed VERISOL ® F, a BCP ® product derived from fish. “Marine collagens are gaining in popularity because they allow manufacturers to meet the needs of consumers preferring others than bovine or porcine collagen due to religious or ethical reasons,” says Dr Stephan Hausmanns. “VERISOL ® F offers the same benefits as VERISOL ® , ensuring the same end results for users.” For more information, please contact Oliver Wolf Head of B2B Marketing, global GELITA AG www.GELITA.com The effects of VERISOL ® F were scientifically confirmed in a study by Proksch et al, in Kiel, Germany. 3 The randomized, controlled trial was carried out with two groups of healthy women aged between 35 and 80. One group was given VERISOL ® , while the other was assigned a No. 3 November/December 2021 47
